Vault-13

Atle Fund Management AB

STOCKHOLM, V7 · CIK 1381843 · 13F filing filed 2026-07-24

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$371.7m reported value +20.0% vs Q1 2026
39positions
48.0%in top 10
3 new 16 added 20 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ELI LILLY & CO COM LLY LLY 29,821 $35.8m9.62% 9.62% ReducedShares held: Q3 2025 37.2k, Q4 2025 31.1k, Q1 2026 39.7k, Q2 2026 29.8k -9.9k -9,901 -24.9%
2 MERCK & CO INC COM MRK MRK 189,357 $24.3m6.55% 6.55% AddedShares held: Q3 2025 160.9k, Q4 2025 195.8k, Q1 2026 33.9k, Q2 2026 189.4k +155.5k +155,504 459.4%
3 JOHNSON & JOHNSON COM JNJ JNJ 85,425 $21.7m5.84% 5.84% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 92.4k, Q2 2026 85.4k -7.0k -6,952 -7.5%
4 ABBVIE INC COM ABBV ABBV 64,325 $16.2m4.35% 4.35% ReducedShares held: Q3 2025 92.1k, Q4 2025 108.2k, Q1 2026 108.2k, Q2 2026 64.3k -43.9k -43,856 -40.5%
5 CVS HEALTH CORP COM CVS CVS 146,102 $15.1m4.07% 4.07% AddedShares held: Q3 2025 0, Q4 2025 106.5k, Q1 2026 23.8k, Q2 2026 146.1k +122.3k +122,329 514.6%
6 THERMO FISHER SCIENTIFIC INC COM TMO TMO 27,859 $14.0m3.76% 3.76% AddedShares held: Q3 2025 27.1k, Q4 2025 29.9k, Q1 2026 23.0k, Q2 2026 27.9k +4.9k +4,873 21.2%
7 REVOLUTION MEDICINES INC COM RVMD RVMD 73,077 $13.7m3.68% 3.68% ReducedShares held: Q3 2025 85.4k, Q4 2025 90.2k, Q1 2026 617.2k, Q2 2026 73.1k -544.2k -544,168 -88.2%
8 BIOGEN INC COM BIIB BIIB 62,781 $13.6m3.65% 3.65% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 62.8k
9 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 72,898 $12.3m3.31% 3.31% ReducedShares held: Q3 2025 102.6k, Q4 2025 94.8k, Q1 2026 89.7k, Q2 2026 72.9k -16.8k -16,787 -18.7%
10 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 100,807 $11.8m3.17% 3.17% ReducedShares held: Q3 2025 93.6k, Q4 2025 89.7k, Q1 2026 195.8k, Q2 2026 100.8k -95.0k -94,961 -48.5%
11 ALKERMES PLC SHS ALKS ALKS 213,329 $11.2m3.01% 3.01% ReducedShares held: Q3 2025 252.9k, Q4 2025 242.5k, Q1 2026 242.5k, Q2 2026 213.3k -29.1k -29,144 -12.0%
12 IONIS PHARMACEUTICALS INC COM IONS IONS 137,131 $10.9m2.93% 2.93% AddedShares held: Q3 2025 0, Q4 2025 92.4k, Q1 2026 27.9k, Q2 2026 137.1k +109.3k +109,258 392.0%
13 BEIGENE LTD SPONSORED ADR ONC ONC 35,180 $10.0m2.70% 2.70% ReducedShares held: Q3 2025 30.3k, Q4 2025 40.4k, Q1 2026 41.7k, Q2 2026 35.2k -6.5k -6,537 -15.7%
14 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 24,656 $9.8m2.64% 2.64% ReducedShares held: Q3 2025 19.7k, Q4 2025 22.3k, Q1 2026 70.9k, Q2 2026 24.7k -46.2k -46,195 -65.2%
15 STRYKER CORPORATION COM SYK SYK 30,283 $9.5m2.57% 2.57% AddedShares held: Q3 2025 22.8k, Q4 2025 26.8k, Q1 2026 26.8k, Q2 2026 30.3k +3.4k +3,448 12.8%
16 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 19,131 $9.5m2.56% 2.56% ReducedShares held: Q3 2025 17.8k, Q4 2025 23.0k, Q1 2026 23.0k, Q2 2026 19.1k -3.9k -3,853 -16.8%
17 EDWARDS LIFESCIENCES CORP COM EW EW 103,230 $9.3m2.51% 2.51% ReducedShares held: Q3 2025 65.7k, Q4 2025 0, Q1 2026 106.5k, Q2 2026 103.2k -3.3k -3,288 -3.1%
18 BRIDGEBIO PHARMA INC COM BBIO BBIO 124,707 $9.3m2.50% 2.50% AddedShares held: Q3 2025 174.7k, Q4 2025 141.3k, Q1 2026 111.4k, Q2 2026 124.7k +13.3k +13,344 12.0%
19 KRYSTAL BIOTECH INC COM KRYS KRYS 24,019 $8.9m2.40% 2.40% ReducedShares held: Q3 2025 42.2k, Q4 2025 33.9k, Q1 2026 37.6k, Q2 2026 24.0k -13.6k -13,560 -36.1%
20 CENCORA INC COM COR COR 31,126 $8.8m2.37% 2.37% AddedShares held: Q3 2025 28.6k, Q4 2025 23.8k, Q1 2026 23.5k, Q2 2026 31.1k +7.7k +7,656 32.6%
21 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 248,848 $8.4m2.27% 2.27% AddedShares held: Q3 2025 193.6k, Q4 2025 197.0k, Q1 2026 94.8k, Q2 2026 248.8k +154.1k +154,052 162.5%
22 ABIVAX SA SPONSORED ADS ABVX ABVX 58,170 $7.8m2.09% 2.09% AddedShares held: Q3 2025 0, Q4 2025 31.6k, Q1 2026 31.6k, Q2 2026 58.2k +26.6k +26,580 84.1%
23 INCYTE CORP COM INCY INCY 56,953 $6.5m1.74% 1.74% AddedShares held: Q3 2025 0, Q4 2025 70.9k, Q1 2026 50.8k, Q2 2026 57.0k +6.2k +6,157 12.1%
24 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 54,102 $6.4m1.73% 1.73% AddedShares held: Q3 2025 30.0k, Q4 2025 37.6k, Q1 2026 22.3k, Q2 2026 54.1k +31.8k +31,780 142.4%
25 BOSTON SCIENTIFIC CORP COM BSX BSX 146,381 $6.2m1.68% 1.68% AddedShares held: Q3 2025 86.7k, Q4 2025 108.7k, Q1 2026 40.4k, Q2 2026 146.4k +105.9k +105,949 262.0%
26 INSMED INC COM PAR $.01 INSM INSM 58,378 $6.2m1.67% 1.67% ReducedShares held: Q3 2025 0, Q4 2025 27.9k, Q1 2026 97.4k, Q2 2026 58.4k -39.1k -39,060 -40.1%
27 TANGO THERAPEUTICS INC COM TNGX TNGX 198,557 $6.2m1.67% 1.67% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 29.9k, Q2 2026 198.6k +168.6k +168,642 563.7%
28 GILEAD SCIENCES INC COM GILD GILD 46,142 $5.8m1.57% 1.57% ReducedShares held: Q3 2025 78.2k, Q4 2025 50.8k, Q1 2026 48.0k, Q2 2026 46.1k -1.8k -1,825 -3.8%
29 CARDINAL HEALTH INC COM CAH CAH 23,630 $5.6m1.51% 1.51% ReducedShares held: Q3 2025 30.3k, Q4 2025 23.5k, Q1 2026 108.7k, Q2 2026 23.6k -85.1k -85,052 -78.3%
30 ORUKA THERAPEUTICS INC COM ORKA ORKA 54,886 $5.2m1.41% 1.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 54.9k
31 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 57,030 $5.1m1.36% 1.36% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.7k, Q2 2026 57.0k -5.7k -5,705 -9.1%
32 DEXCOM INC COM DXCM DXCM 71,846 $4.8m1.30% 1.30% ReducedShares held: Q3 2025 50.9k, Q4 2025 39.7k, Q1 2026 584.3k, Q2 2026 71.8k -512.5k -512,486 -87.7%
33 BICARA THERAPEUTICS INC COM BCAX BCAX 145,657 $4.3m1.16% 1.16% ReducedShares held: Q3 2025 203.8k, Q4 2025 111.4k, Q1 2026 1.2m, Q2 2026 145.7k -1.0m -1,023,977 -87.5%
34 IDEAYA BIOSCIENCES INC COM IDYA IDYA 94,478 $3.5m0.95% 0.95% AddedShares held: Q3 2025 0, Q4 2025 97.4k, Q1 2026 31.1k, Q2 2026 94.5k +63.3k +63,345 203.5%
35 CELCUITY INC COM CELC CELC 33,313 $3.5m0.94% 0.94% ReducedShares held: Q3 2025 37.2k, Q4 2025 41.8k, Q1 2026 141.3k, Q2 2026 33.3k -108.0k -107,983 -76.4%
36 DISC MEDICINE INC COM IRON IRON 43,682 $3.2m0.86% 0.86% ReducedShares held: Q3 2025 45.7k, Q4 2025 48.0k, Q1 2026 107.3k, Q2 2026 43.7k -63.6k -63,573 -59.3%
37 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 966,459 $2.9m0.78% 0.78% AddedShares held: Q3 2025 0, Q4 2025 617.2k, Q1 2026 197.0k, Q2 2026 966.5k +769.4k +769,423 390.5%
38 COMPASS THERAPEUTICS INC COM CMPX CMPX 1,048,593 $2.3m0.62% 0.62% AddedShares held: Q3 2025 0, Q4 2025 584.3k, Q1 2026 41.8k, Q2 2026 1.0m +1.0m +1,006,762 2406.7%
39 JADE BIOSCIENCES INC COM NEW JBIO JBIO 88,556 $2.0m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 88.6k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
AMGEN INC AMGN AMGN 21,903 $8.7m21.9k shares
UNITEDHEALTH GROUP INC UNH UNH 14,636 $2.8m14.6k shares
SOLENO THERAPEUTICS INC SLNO SLNO 90,184 $2.2m90.2k shares